Assessing ChatGPT-4 as a clinical decision support tool in neuro-oncology radiotherapy: a prospective comparative study - Takeaways - MDSpire

Assessing ChatGPT-4 as a clinical decision support tool in neuro-oncology radiotherapy: a prospective comparative study

  • By

  • Paolo Tini

  • Federica Novi

  • Flavio Donnini

  • Armando Perrella

  • Giulio Bagnacci

  • Maria Antonietta Mazzei

  • Giuseppe Minniti

  • October 15, 2025

  • 0 min

Share

  • 1

    ChatGPT-4 was evaluated as a clinical decision support tool for radiotherapy in neuro-oncology through a prospective observational study.

  • 2

    The study included 101 cases of central nervous system tumors, assessing ChatGPT-4's recommendations against expert decisions.

  • 3

    Cases were classified by complexity, revealing varying performance of ChatGPT-4 based on the clarity of treatment guidelines.

  • 4

    Findings indicate that while ChatGPT-4 can provide recommendations, its accuracy and reliability in complex cases remain uncertain.

  • 5

    The study highlights the potential and limitations of integrating AI tools like ChatGPT-4 into clinical workflows in oncology.

Original Source(s)

Related Content